BACKGROUND: Multiple sclerosis results from T-cell-dependent inflammatory demyelination of the central nervous system. Our objective was long-term suppression of inflammation with short-term monoclonal antibody treatment. METHODS: We depleted 95% of circulating lymphocytes in 27 patients with multiple sclerosis by means of a 5-day pulse of the humanised anti-CD52 monoclonal antibody, Campath-1H. Clinical and haematological consequences of T-cell depletion, and in-vitro responses of patients'...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
If you are the owner of this record, you can report an update to it here: Report update to this record